DK1224166T3 - Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid - Google Patents

Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid

Info

Publication number
DK1224166T3
DK1224166T3 DK00972725T DK00972725T DK1224166T3 DK 1224166 T3 DK1224166 T3 DK 1224166T3 DK 00972725 T DK00972725 T DK 00972725T DK 00972725 T DK00972725 T DK 00972725T DK 1224166 T3 DK1224166 T3 DK 1224166T3
Authority
DK
Denmark
Prior art keywords
preparation
methanesulfonyl
benzoyl
bis
methyl
Prior art date
Application number
DK00972725T
Other languages
Danish (da)
English (en)
Inventor
Rolf Gericke
Manfred Baumgarth
Hans Markus Bender
Bernhard Ladstetter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1224166T3 publication Critical patent/DK1224166T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00972725T 1999-10-26 2000-10-11 Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid DK1224166T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951418A DE19951418A1 (de) 1999-10-26 1999-10-26 Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
PCT/EP2000/009977 WO2001030750A1 (fr) 1999-10-26 2000-10-11 Procede de fabrication de chlorhydrate de n-(4,5-bismethanesulfonyl-2-methyl-benzoyl)-guanidine

Publications (1)

Publication Number Publication Date
DK1224166T3 true DK1224166T3 (da) 2004-01-05

Family

ID=7926842

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00972725T DK1224166T3 (da) 1999-10-26 2000-10-11 Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid

Country Status (26)

Country Link
US (1) US6673968B1 (fr)
EP (1) EP1224166B1 (fr)
JP (1) JP4969750B2 (fr)
KR (1) KR100699571B1 (fr)
CN (1) CN1202078C (fr)
AT (1) ATE250026T1 (fr)
AU (1) AU782471B2 (fr)
BR (1) BR0015022A (fr)
CA (1) CA2388915C (fr)
CZ (1) CZ299201B6 (fr)
DE (2) DE19951418A1 (fr)
DK (1) DK1224166T3 (fr)
ES (1) ES2204712T3 (fr)
HK (1) HK1051358A1 (fr)
HU (1) HU228634B1 (fr)
MX (1) MXPA02004144A (fr)
MY (1) MY122651A (fr)
NO (1) NO328250B1 (fr)
PL (1) PL199010B1 (fr)
PT (1) PT1224166E (fr)
RU (1) RU2276134C2 (fr)
SI (1) SI1224166T1 (fr)
SK (1) SK286603B6 (fr)
UA (1) UA73329C2 (fr)
WO (1) WO2001030750A1 (fr)
ZA (1) ZA200204119B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
JP2006525247A (ja) * 2003-05-06 2006-11-09 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング グアニジン塩を結晶化する方法
HUE026025T2 (en) * 2008-05-09 2016-05-30 Merck Patent Gmbh A pharmaceutical composition comprising rimeporide for the treatment of diseases associated with beta cell dysfunction
JOP20200296A1 (ar) * 2013-06-10 2017-06-16 Amgen Inc عمليات صنع وأشكال بلورية من mdm2 مثبط
US9765097B2 (en) * 2014-06-23 2017-09-19 Nissan Chemical Industries, Ltd. Method for producing silane compound having sulfonyl bond
CN108602767A (zh) * 2016-02-08 2018-09-28 默克专利股份有限公司 N-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐酸盐和n-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐的结晶变体
EP3960165A1 (fr) * 2020-08-25 2022-03-02 Fondation EspeRare Inhibiteurs de nhe-1 pour le traitement des infections à coronavirus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216865A (ja) * 1983-05-26 1984-12-06 Mitsui Toatsu Chem Inc システイン塩酸塩水和物の乾燥方法
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0589336T3 (da) * 1992-09-22 1997-06-16 Hoechst Ag Benzylguanidiner, fremgangsmåde til deres fremstilling samt deres anvendelse som antiarytmetika
EP0604852A1 (fr) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 5-Sulfamoylbenzoylguanidines 2,4,N-substituées, comme agents antiarhythmiques, inhibiteurs de la prolifération des cellules, et inhibiteurs de l'écharge sodium-hydrogène
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
ES2139965T3 (es) * 1995-01-30 2000-02-16 Hoechst Ag Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
AU782471B2 (en) 2005-08-04
HUP0203132A2 (hu) 2003-01-28
DE50003759D1 (de) 2003-10-23
NO20021950L (no) 2002-04-25
MXPA02004144A (es) 2006-01-12
EP1224166A1 (fr) 2002-07-24
PL355149A1 (en) 2004-04-05
HUP0203132A3 (en) 2004-12-28
CZ20021354A3 (cs) 2002-09-11
AU1136101A (en) 2001-05-08
BR0015022A (pt) 2002-06-18
EP1224166B1 (fr) 2003-09-17
SI1224166T1 (en) 2004-04-30
CZ299201B6 (cs) 2008-05-14
KR20020044572A (ko) 2002-06-15
ZA200204119B (en) 2003-10-29
CN1202078C (zh) 2005-05-18
ES2204712T3 (es) 2004-05-01
HU228634B1 (en) 2013-04-29
JP4969750B2 (ja) 2012-07-04
KR100699571B1 (ko) 2007-03-23
PL199010B1 (pl) 2008-08-29
UA73329C2 (uk) 2005-07-15
ATE250026T1 (de) 2003-10-15
MY122651A (en) 2006-04-29
PT1224166E (pt) 2004-02-27
CA2388915A1 (fr) 2001-05-03
SK5462002A3 (en) 2002-10-08
NO20021950D0 (no) 2002-04-25
NO328250B1 (no) 2010-01-18
JP2003512451A (ja) 2003-04-02
CN1382120A (zh) 2002-11-27
HK1051358A1 (en) 2003-08-01
DE19951418A1 (de) 2001-05-03
RU2276134C2 (ru) 2006-05-10
CA2388915C (fr) 2009-12-15
US6673968B1 (en) 2004-01-06
WO2001030750A1 (fr) 2001-05-03
SK286603B6 (sk) 2009-02-05

Similar Documents

Publication Publication Date Title
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
ATE465146T1 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
DK1542977T3 (da) 2,5-dioxoimidazolidin-4-ylacetamider og analoger som inhibitorer af metalloproteinase MMP12
DK0956282T3 (da) Sulfinsyrederivater, fremgangsmåde til deres fremstilling og anvendelse
IS7220A (is) Latar af þætti XA og öðrum rað-próteösum sem tengjast storknunar keðjuverkun
DK1200418T3 (da) Nematodicide trifluorbutener
KR960702830A (ko) 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents)
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
EA200400280A1 (ru) Новые неочищенные и кристаллические формы гидрохлорида лерканидипина
DK1224166T3 (da) Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid
DK0870763T3 (da) Kondenserede piperidinderivater som inhibitorer for syntese af nitrogenmonoxid
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE315026T1 (de) Amlodipin-hemimaleat
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DE50311388D1 (de) Nicht-peptidische brs-3-agonisten
DK0906309T3 (da) Modificeret form af R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotinsyre-hydrochloridet
DK0703232T3 (da) 2,3-Dihydro-1H-isoindolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som hæmmere af serotoningenoptagelsen
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
ATE242763T1 (de) Methoximinophenylessigsäureamide
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
NO20021821L (no) Natrium-hydrogen utvekslingstype 1 inhibitor krystaller
AR026231A1 (es) Proceso para preparar clorhidrato de n-(4,5-bis-metansulfonil-2-metilbenzoil)-guanidina